USPTO serial 88267045
SHARPS PROVENSA ULTRA-LOW WASTE
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- KLEINMAN, CORINNE ANNE
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with SHARPS PROVENSA ULTRA-LOW WASTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Todd Braverman, Esq.
Todd Braverman, Esq. Todd Braverman & Associates, P.C. dba Trademarkauthority223 McKinley TerraceCenterport, NY 11721United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and needles all pre-filled with vaccines, biological preparations for the treatment of a wide variety of diseases, conditions, and disorders, pharmaceutical preparations for the prevention and treatment of a wide variety of diseases, conditions, and disorders, antibiotics, and anti-diabetic preparations and pharmaceuticals | ACTIVE | — |
| 035 | Online retail store and online retail services through direct solicitation by distributors directed to end-users featuring syringes and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; online retail store and online retail services through direct solicitation by distributors directed to end-users featuring disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine; consulting services in the fields of consumer product information of medical instruments, syringes, and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; consulting services in the fields of consumer product information of medical instruments disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine; providing consumer product information via a web site on medical instruments, syringes and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; providing consumer product information via a web site on medical instruments regarding the repair and maintenance of medical instruments, disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine | ACTIVE | — |
| 042 | Consulting services in the fields of product development of medical instruments, syringes and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; consulting services in the fields of product development of medical instruments disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine; providing information via a web site on product development of medical instruments, syringes and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; providing information via a web site on product development of medical instruments, disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine | ACTIVE | — |
| 044 | Consulting services in the fields of medical instruments regarding the use and operation of medical instruments, syringes and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; consulting services in the fields of medical instruments regarding the use and operation of medical instruments disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine; providing information via a web site on medical instruments regarding the use and operation of medical instruments, syringes and needles for medical use and for injection, disposable syringes and needles for medical use and for injection, disposable hypodermic syringes and needles for medical use and for injection, and hypodermic syringes, hypodermic needle for medical use and for injection; providing information via a web site on medical instruments regarding the use and operation of medical instruments, disposable hypodermic syringes and needles, injection needles, injection syringes, syringes, and hypodermic needles all pre-filled with vaccines, biologicals, pharmaceuticals, antibiotics, and diabetes medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sharps Technology, Inc.
- Other trademarks owned by Sharps Technology, Inc.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SHARPS PROVENSA ULTRA-LOW WASTE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 5, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 5, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 5, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 12, 2022 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Dec 12, 2022 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| May 5, 2022 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| May 4, 2022 | EX5G | SOU EXTENSION 5 GRANTED | — |
| May 2, 2022 | EXT5 | SOU EXTENSION 5 FILED | — |
| May 2, 2022 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 9, 2021 | NOAC | CORRECTED NOA E-MAILED | — |
| Nov 9, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 8, 2021 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Nov 8, 2021 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 5, 2021 | EXT4 | SOU EXTENSION 4 FILED | — |
| Nov 5, 2021 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Nov 5, 2021 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Nov 5, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 21, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Apr 21, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Apr 21, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Apr 13, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 9, 2021 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 9, 2021 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 9, 2021 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 27, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 23, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 23, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 23, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| May 12, 2020 | IULN | ITU LETTER MAILED, NO RESPONSE REQUIRED | — |
| May 12, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| May 1, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 29, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 29, 2020 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 29, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Apr 29, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 5, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Sep 10, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 10, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 8, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Aug 8, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Aug 8, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Aug 8, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Aug 8, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 20, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 20, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jul 15, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 14, 2019 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 14, 2019 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Mar 14, 2019 | EPEN | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | — |
| Mar 14, 2019 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Mar 4, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 10, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 22, 2019 | NWAP | NEW APPLICATION ENTERED | — |